Financial Performance - The company's revenue for Q3 2021 reached ¥6,125,581,416.78, an increase of 68.61% compared to the same period last year[4] - Net profit attributable to shareholders was ¥761,521,466.24, representing a significant increase of 183.88% year-on-year[4] - The net profit excluding non-recurring gains and losses was ¥694,683,983.89, up 852.35% compared to the previous year[4] - The basic earnings per share for the period was ¥0.848, reflecting an increase of 183.86% year-on-year[4] - In Q3 2021, the company achieved its highest quarterly profit in history, driven by stable high operating levels and maintained high prices for its main products[15] - Total operating revenue for the current period reached ¥15,474,519,629.55, a significant increase from ¥9,778,022,078.67 in the previous period, representing a growth of approximately 58%[26] - Net profit for the current period was ¥1,957,060,231.25, a substantial rise from ¥74,039,844.48 in the previous period, reflecting a growth of over 2,500%[29] - The total comprehensive income for the current period was ¥1,958,164,884.75, compared to ¥74,039,844.48 in the previous period, showing a remarkable increase[32] Assets and Liabilities - Total assets at the end of the reporting period were ¥20,388,522,584.74, a decrease of 7.39% from the end of the previous year[4] - As of September 30, 2021, the company's total assets amounted to approximately CNY 20.39 billion, a decrease from CNY 22.02 billion at the end of 2020[19] - The company’s non-current assets totaled approximately CNY 13.67 billion, down from CNY 15.41 billion, indicating a strategic focus on asset efficiency[21] - The total liabilities decreased from ¥20,672,143,267.13 to ¥16,977,657,903.59, a reduction of about 17%[25] - The company's current liabilities decreased to CNY 9.86 billion from CNY 11.86 billion year-over-year, reflecting improved financial health[21] - Long-term borrowings decreased to CNY 6.63 billion from CNY 7.60 billion, indicating a reduction in debt levels[21] Cash Flow - Cash flow from operating activities for the year-to-date was ¥3,143,395,943.81, an increase of 242.72% compared to the previous year[4] - Cash flow from operating activities for the current period was ¥14,801,921,473.56, compared to ¥9,581,088,164.38 in the previous period, indicating an increase of about 54%[34] - The net cash flow from operating activities was CNY 3,143,395,943.81, a significant increase from CNY 917,203,685.83 in the previous period, reflecting a growth of approximately 243%[37] - Cash inflow from investment activities totaled CNY 1,856,377,337.07, compared to CNY 215,602,757.80 in the prior period, indicating a substantial increase[37] - The net cash flow from financing activities was negative at CNY -4,178,091,355.86, worsening from CNY -377,568,786.12 in the previous year[40] Expenses and Investments - Research and development expenses increased by 78% year-on-year, indicating a focus on enhancing innovation[7] - The company reported a significant increase in research and development expenses, totaling ¥422,992,560.58, compared to ¥237,895,137.33 in the previous period, marking an increase of approximately 77%[29] - The cash outflow for purchasing fixed assets was CNY 688,735,129.49, compared to CNY 476,188,803.47 in the prior year, reflecting an increase of about 44%[37] Equity and Shareholder Information - The total equity attributable to shareholders of the parent company increased from ¥326,207,863.93 to ¥1,891,538,751.98, representing a growth of approximately 479%[25] - The company reported a basic earnings per share of ¥1.656, a significant improvement from a loss of ¥0.003 in the previous period[32] Other Significant Events - The company completed the transfer of 100% equity in Hunan Yihua Chemical Co., Ltd., enhancing its focus on core business operations[15] - The company initiated the bankruptcy liquidation of Hubei Xiangxi Chemical Co., Ltd., aimed at divesting low-efficiency assets[15] - The company received government subsidies amounting to ¥21,335,184.20 during the reporting period, contributing to its financial performance[6]
湖北宜化(000422) - 2021 Q3 - 季度财报